372
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Reve Technologies, Inc., a drug development company, provides advanced therapeutics for the treatment of cancer. It offers irreversible pepsin fraction (IPF), a therapeutic platform technology that is used to facilitate a range of applications. The company's solution is also used for the treatment of autoimmune diseases, such as cirrhosis and Hepatitis C.

Similar securities

Based on sector and market capitalization

Report issue